Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Laboratory Facility Manager
International AIDS Vaccine Initiative - New York, NY
Scientist/Sr. Scientist, Bio-analytical Chemistry
Dicerna Pharmaceuticals, Inc. - Watertown, MA
Analyst, Procurement Operations Job
Celgene Corporation - Basking Ridge, NJ, US
Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US
Clinical Research Coordinator
Lovelace Respiratory Research Institute - Albuquerque, NM

More Jobs >>

Events

Biomarker Applications for Improved Clinical Trial Outcomes
Nov. 15-16 — Boston
CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami
New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
Life Science in the Cloud
Nov 16, 2011 — Cambridge, MA

More Events >>

J. Craig Venter News

Most Popular J. Craig Venter Story

Novartis and Venter team on faster vaccine development

October 7, 2010 — 6:58am ET | By John Carroll

Novartis is turning to J. Craig Venter to help blaze a development shortcut that can carve weeks off the time it takes to ramp up production of a new flu vaccine. One of the bottlenecks that appeared Read more...

J. Craig Venter Press Releases

J. Craig Venter Institute Breaks Ground on La Jolla, California's First True Sustainable Laboratory Facility
PRESS RELEASE: First Individual Diploid Human Genome Published By Researchers at J. Craig Venter Institute

Latest Headlines

Novartis and Venter team on faster vaccine development
October 7, 2010

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK